Meridian Bioscience, Inc. Reports Second Quarter 2014 Operating Results And Revises Fiscal 2014 Guidance

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Meridian Bioscience, Inc. (NASDAQ: VIVO):


Meridian Bioscience, Inc. (NASDAQ: VIVO) today:

•reported record fiscal 2014 second quarter and first six months net sales of $50.1 million and $94.9 million, respectively, increases of 6% and 2%, respectively, from the same periods of the prior fiscal year

Help employers find you! Check out all the jobs and post your resume.

Back to news